Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06591091
PHASE2
Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
Sponsor: University of Illinois at Chicago
View on ClinicalTrials.gov
Summary
The goal of this study is to find out if the antihistamine, clemastine, can make the white matter in the brain better in older adults with depression. The study will also determine whether this improvement can make antidepressant treatment work better, reduce depressive symptoms, and improve memory and thinking.
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-09
Completion Date
2026-03
Last Updated
2025-09-04
Healthy Volunteers
No
Conditions
Interventions
DRUG
Clemastine Fumarate
Listed in arm/group description
DRUG
Placebo
Listed in arm/group description